GB982072A - Benzothiadiazine-1,1-dioxides and processes for their manufacture - Google Patents

Benzothiadiazine-1,1-dioxides and processes for their manufacture

Info

Publication number
GB982072A
GB982072A GB1012561A GB1012561A GB982072A GB 982072 A GB982072 A GB 982072A GB 1012561 A GB1012561 A GB 1012561A GB 1012561 A GB1012561 A GB 1012561A GB 982072 A GB982072 A GB 982072A
Authority
GB
United Kingdom
Prior art keywords
rco
formula
amino
sulphonamide
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1012561A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scherico Ltd
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US83357A external-priority patent/US2986573A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Priority to CH1081761A priority Critical patent/CH436314A/en
Priority to DE1961SC030290 priority patent/DE1445147C3/en
Priority to SE930561A priority patent/SE307583B/xx
Priority to BE608298A priority patent/BE608298A/en
Priority to DK371561A priority patent/DK120397B/en
Priority to DK544462A priority patent/DK121233B/en
Publication of GB982072A publication Critical patent/GB982072A/en
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises compounds of the formula <FORM:0982072/C2/1> and the tautomers and alkali-metal salts thereof wherein X represents halogen or trifluoromethyl in the 6- or 7-position, Y represents hydrogen or a halogen, methyl or trifluoromethyl substituent in the 6-, 7- or 8-position and R is a saturated aliphatic hydrocarbon group of not more than 6 carbon atoms, e.g. alkyl or cycloalkyl such as cyclopropyl; and their preparation by (a) heating a compound of the formula <FORM:0982072/C2/2> wherein Z is H, benzyl or a lower aliphatic hydrocarbon group, Q may be (H,H), (H, RCO-), (RCO-, RCO-) or RC(O.lower alkyl) = and T is H or R.CO-, provided that when Z is methyl or ethyl Q is not RC(O.lower alkyl) = and that when Q and T is hydrogen, the heating is effected in the presence of a lower saturated aliphatic monocarboxylic acid R.COOH, or an ester, anhydride, acid halide or ortho ester thereof, or an a -lower alkoxy-aldehyde diacetal; (b) heating an X,Y-substituted-2-sulphamyl aniline with an ortho ester of the formula R.C(O.lower alkyl)3 or an acid RCOOH or ester, anhydride or halide thereof; (c) dehydrogenating the corresponding 3,4 - dihydro - benzothiadiazine analogue by treatment with a mild oxidizing agent such as potassium permanganate; or (d) removing hydrogen halide from a corresponding 3,4-dihydro-benzothiadiazine analogue bearing an a -haloalkyl group in place of the alkyl group R. Sulphamylanilines of the formula II are made by treating an X,Y-substituted-o-chloronitrobenzene with thiourea and benzyl chloride to give the corresponding o-benzylthio-nitrobenzene, oxidizing with chlorine to the o-nitrobenzenesulphonyl chloride, reacting with ammonia to give the sulphonamide, reducing to the o-aminobenzenesulphonamide and acylating to introduce groups RCO- on the amino and/or sulphonamido nitrogen atom, or acylating the nitrobenzenesulphonamide followed by reduction to give products acylated on the sulphonamide group only. Alternatively an X,Y-substituted o-amino-benzenesulphonamide bearing a lower aliphatic hydrocarbon or a benzyl substituent on the sulphonamide nitrogen atom may be treated an ortho ester R(COC2H5)3 to form a corresponding sulphonamide bearing an a -alkoxyalkylidene-amino substituent, e.g. R.C(OC2H5) =, in the o-position. o - Diacylamino - benzenesulphonic acids bearing substituents X and Y, in which the acyl groups are of the formula RCO-, are prepared by reacting the appropriate 2-amino-benzenesulphonic acid (e.g. 2-amino-5-chloro-benzenesulphonic acid) with an acylating agent of the formula RCOCl, (RCO)2O or R COONa (e.g. acetic anhydride). Pharmaceutical preparations having blood pressure lowering activity comprise the above compounds of the invention and a carrier suitable for enteral or parenteral administration, for example in the form of tablets, capsules, suppositories, elixirs, emulsions or injectable preparations.
GB1012561A 1960-09-19 1961-03-20 Benzothiadiazine-1,1-dioxides and processes for their manufacture Expired GB982072A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CH1081761A CH436314A (en) 1960-09-19 1961-09-13 Process for the production of new therapeutically active substances
DE1961SC030290 DE1445147C3 (en) 1960-09-19 1961-09-16 3-methyl-7-chloro-lÄ4-benzothiadiazine-l, l-dioxyde
SE930561A SE307583B (en) 1960-09-19 1961-09-19
BE608298A BE608298A (en) 1960-09-19 1961-09-19 New therapeutic compounds and their manufacturing processes.
DK371561A DK120397B (en) 1960-09-19 1961-09-19 Process for the preparation of 3-substituted 1,2,4-benzothiadiazine-1,1-dioxide compounds or salts thereof.
DK544462A DK121233B (en) 1961-02-20 1962-12-15 Process for the preparation of 3-substituted 1,2,4-benzothiadiazine-1,1-dioxide compounds or salts thereof.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5667160A 1960-09-19 1960-09-19
US8337761A 1961-01-18 1961-01-18
US83357A US2986573A (en) 1961-01-18 1961-01-18 Method for the treatment of hypertension
US9019861A 1961-02-20 1961-02-20

Publications (1)

Publication Number Publication Date
GB982072A true GB982072A (en) 1965-02-03

Family

ID=27489824

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1012561A Expired GB982072A (en) 1960-09-19 1961-03-20 Benzothiadiazine-1,1-dioxides and processes for their manufacture

Country Status (1)

Country Link
GB (1) GB982072A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572789B2 (en) 2006-01-05 2009-08-11 Essentialis, Inc. Salts of potassium ATP channel openers and uses thereof
US9765043B2 (en) 2012-02-27 2017-09-19 Essentialls, Inc. Salts of potassium ATP channel openers and uses thereof
US9782416B2 (en) 2004-08-25 2017-10-10 Essentialis, Inc. Pharmaceutical formulations of potassium ATP channel openers and uses thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9782416B2 (en) 2004-08-25 2017-10-10 Essentialis, Inc. Pharmaceutical formulations of potassium ATP channel openers and uses thereof
US7572789B2 (en) 2006-01-05 2009-08-11 Essentialis, Inc. Salts of potassium ATP channel openers and uses thereof
US7799777B2 (en) 2006-01-05 2010-09-21 Essentialis, Inc. Salts of potassium ATP channel openers and uses thereof
EP2404604A1 (en) 2006-01-05 2012-01-11 Essentialis, Inc. Salts of potassium ATP channel openers and uses thereof
US10085998B2 (en) 2006-01-05 2018-10-02 Essentialis, Inc. Salts of potassium ATP channel openers and uses thereof
EP3545958A1 (en) 2006-01-05 2019-10-02 Essentialis, Inc. Salts of potassium atp channel openers and uses thereof
US11045478B2 (en) 2006-01-05 2021-06-29 Essentialis, Inc. Salts of potassium ATP channel openers and uses thereof
US11786536B2 (en) 2006-01-05 2023-10-17 Essentialis, Inc. Salts of potassium ATP channel openers and uses thereof
US9765043B2 (en) 2012-02-27 2017-09-19 Essentialls, Inc. Salts of potassium ATP channel openers and uses thereof

Similar Documents

Publication Publication Date Title
GEP19960467B (en) Method of producing derivatives of quinoline or their pharmaceutically acceptable esters or acid-additive salts
GB1069343A (en) Propanolamine derivatives
GB1331405A (en) Esters their production and their medicinal use
GB1469986A (en) Chromium salt compositions and to a process for their production
GB949088A (en) Diazabicyclo-octane derivatives
EP0217287A3 (en) Û(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1h-fluoren-7-yl)-oxy¨ethanimidamides and û(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1h-fluoren-7yl)oxy¨ethanimidic acid hydrazides, their derivatives and their salts
EP0143123A3 (en) Industrial products useful as intermediates in the preparation of 4-hydroxy-3 quinoleine carboxamide derivatives substituted at position 2, and the preparation of these intermediates
GB982072A (en) Benzothiadiazine-1,1-dioxides and processes for their manufacture
GB1016356A (en) Preparation of organic peroxycarboxylic acids
ES274606A1 (en) Benzoic acid ester derivatives for treating coccidiosis and method of using same
GB1018117A (en)
GB1356437A (en) Process for the manufacture of cephalosporanic acid derivatives and the derivatives thus obtainable
GB1123466A (en) Process for the production of cyanamide dicarboxylic acid esters
GB898909A (en) New naphthalene compounds and process for their manufacture
GB1340512A (en) Production of esters of chromone-2-carboxylic acids
ES271094A1 (en) Procedure for the obtaining of trihydroxamic acids of long chains (Machine-translation by Google Translate, not legally binding)
GB1088265A (en) Process for preparing 2, 3-epithioandrostane esters
GB1482380A (en) Phenylbutazone derivatives
GB876516A (en) Antibacterial agents
GB1165633A (en) Substituted Phenoxyfluoroacetic Acids and their preparation
GB1355330A (en) Preparation of azetidin-2-one derivatives
GB1346401A (en) Cardioactive arylaminobutanols
GB911489A (en) Serine derivative
GB872708A (en) Pyrrolo-[2, 1-ª-]-isoindoles and process for the production thereof
JPS51115481A (en) Process for preparation of (3,4-dihydro-6-carbostyril)carboxylic and e ster derivatives